Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EFFECTS OF LINAGLIPTIN ON ACTIVE GLP-1 CONCENTRATIONS IN SUBJECTS WITH RENAL IMPAIRMENT

NCT01903070 is registered in ClinicalTrials.gov with Profil Institut für Stoffwechselforschung GmbH as lead sponsor.

NCT NCT01903070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01903070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EFFECTS OF LINAGLIPTIN ON ACTIVE GLP-1 CONCENTRATIONS IN SUBJECTS WITH RENAL IMPAIRMENT
Lead sponsor
Profil Institut für Stoffwechselforschung GmbH
Phase
Phase 4
Overall status
Completed
Start date
July 11, 2013
Completion date
April 30, 2016
Enrollment
99 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus